These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Hyperhomocysteinemia and low plasma folate as risk factors for central retinal vein occlusion: a case-control study in a Chinese population. Gao W, Wang YS, Zhang P, Wang HY. Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1246-9. PubMed ID: 16538453 [Abstract] [Full Text] [Related]
7. Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion. Di Crecchio L, Parodi MB, Sanguinetti G, Iacono P, Ravalico G. Ophthalmology; 2004 May; 111(5):940-5. PubMed ID: 15121372 [Abstract] [Full Text] [Related]
12. [Cilioretinal artery occlusion and central retinal vein occlusion complicating hyperhomocysteinemia: a case report]. Berkani Z, Kitouni Y, Belhadj A, Sifi K, Abbadi N, Bellatrache C, Hartani D, Kherroubi R. J Fr Ophtalmol; 2013 Sep; 36(7):e119-27. PubMed ID: 23731792 [Abstract] [Full Text] [Related]
13. Plasma homocysteine concentrations in acute and convalescent changes of central retinal vein occlusion in a Chinese population. Dong N, Xu B, Tang X. Invest Ophthalmol Vis Sci; 2014 Jun 06; 55(7):4057-62. PubMed ID: 24906854 [Abstract] [Full Text] [Related]
14. The role of hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with retinal artery occlusion. Weger M, Stanger O, Deutschmann H, Leitner FJ, Renner W, Schmut O, Semmelrock J, Haas A. Am J Ophthalmol; 2002 Jul 06; 134(1):57-61. PubMed ID: 12095808 [Abstract] [Full Text] [Related]
15. Hyperhomocysteinemia: a risk factor for central retinal vein occlusion. Weger M, Stanger O, Haas A. Am J Ophthalmol; 2001 Feb 06; 131(2):290-1. PubMed ID: 11243255 [No Abstract] [Full Text] [Related]
16. Role of hyperhomocystinemia in retinal vascular occlusive disease. Sottilotta G, Oriana V, Latella C, Luise F, Piromalli A, Ramirez F, Mammi C, Occhiuto A, Lombardo VT. Clin Appl Thromb Hemost; 2007 Jan 06; 13(1):104-7. PubMed ID: 17164500 [Abstract] [Full Text] [Related]
17. Hyperhomocysteinemia, a biochemical tool for differentiating ischemic and nonischemic central retinal vein occlusion during the early acute phase. Lahiri KD, Mukherjee S, Ghosh S, Mukherjee S, Dutta J, Datta H, Das HN. Korean J Ophthalmol; 2015 Apr 06; 29(2):86-91. PubMed ID: 25829824 [Abstract] [Full Text] [Related]
18. Hyperhomocysteinemia and low methionine stress are risk factors for central retinal venous occlusion in an Indian population. Narayanasamy A, Subramaniam B, Karunakaran C, Ranganathan P, Sivaramakrishnan R, Sharma T, Badrinath VS, Roy J. Invest Ophthalmol Vis Sci; 2007 Apr 06; 48(4):1441-6. PubMed ID: 17389469 [Abstract] [Full Text] [Related]
19. Hyperhomocysteinaemia: risk of retinal vascular occlusion. Yaghoubi GH, Madarshahian F, Mosavi M. East Mediterr Health J; 2004 Apr 06; 10(4-5):633-9. PubMed ID: 16335656 [Abstract] [Full Text] [Related]
20. Hyperhomocysteinemia and retinal vascular occlusive disease. Battaglia Parodi M, Di Crecchio L. Eur J Ophthalmol; 2003 Jun 06; 13(5):500; author reply 500-1. PubMed ID: 12841576 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]